OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Correlation between MDSC and Immune Tolerance in Transplantation: Cytokines, Pathways and Cell-cell Interaction
Tianying Yang, Jiawei Li, Ruimin Li, et al.
Current Gene Therapy (2019) Vol. 19, Iss. 2, pp. 81-92
Closed Access | Times Cited: 14
Tianying Yang, Jiawei Li, Ruimin Li, et al.
Current Gene Therapy (2019) Vol. 19, Iss. 2, pp. 81-92
Closed Access | Times Cited: 14
Showing 14 citing articles:
CCL5/CCR5 axis in human diseases and related treatments
Zhen Zeng, Tianxia Lan, Yuquan Wei, et al.
Genes & Diseases (2021) Vol. 9, Iss. 1, pp. 12-27
Open Access | Times Cited: 206
Zhen Zeng, Tianxia Lan, Yuquan Wei, et al.
Genes & Diseases (2021) Vol. 9, Iss. 1, pp. 12-27
Open Access | Times Cited: 206
Immunosenescence is both functional/adaptive and dysfunctional/maladaptive
Tamàs Fülöp, Anis Larbi, K. Hirokawa, et al.
Seminars in Immunopathology (2020) Vol. 42, Iss. 5, pp. 521-536
Open Access | Times Cited: 88
Tamàs Fülöp, Anis Larbi, K. Hirokawa, et al.
Seminars in Immunopathology (2020) Vol. 42, Iss. 5, pp. 521-536
Open Access | Times Cited: 88
Myeloid-Derived Suppressor Cells in Solid Tumors
Tianmiao Ma, Bernhard W. Renz, Matthias Ilmer, et al.
Cells (2022) Vol. 11, Iss. 2, pp. 310-310
Open Access | Times Cited: 64
Tianmiao Ma, Bernhard W. Renz, Matthias Ilmer, et al.
Cells (2022) Vol. 11, Iss. 2, pp. 310-310
Open Access | Times Cited: 64
The recent progress of myeloid‐derived suppressor cell and its targeted therapies in cancers
Ruiyang Ren, Chenyi Xiong, R.C-S. Ma, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 13
Ruiyang Ren, Chenyi Xiong, R.C-S. Ma, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 13
Immunotherapy and the ovarian cancer microenvironment: Exploring potential strategies for enhanced treatment efficacy
Zhibin Wang, Xiu Zhang, Chao Fang, et al.
Immunology (2024) Vol. 173, Iss. 1, pp. 14-32
Closed Access | Times Cited: 5
Zhibin Wang, Xiu Zhang, Chao Fang, et al.
Immunology (2024) Vol. 173, Iss. 1, pp. 14-32
Closed Access | Times Cited: 5
The impact of cytokines and tumour‐conditioned medium on the properties of murine in vitro generated myeloid‐derived suppressor cells
Mohammed R. Awad, Aleksandra V. Sen’kova, Marina A. Zenkova, et al.
Scandinavian Journal of Immunology (2025) Vol. 101, Iss. 2
Closed Access
Mohammed R. Awad, Aleksandra V. Sen’kova, Marina A. Zenkova, et al.
Scandinavian Journal of Immunology (2025) Vol. 101, Iss. 2
Closed Access
The anti-inflammatory drug dimethyl itaconate protects against colitis-associated colorectal cancer
Qian Wang, Xin Ling Li, Yan Mei, et al.
Journal of Molecular Medicine (2020) Vol. 98, Iss. 10, pp. 1457-1466
Closed Access | Times Cited: 35
Qian Wang, Xin Ling Li, Yan Mei, et al.
Journal of Molecular Medicine (2020) Vol. 98, Iss. 10, pp. 1457-1466
Closed Access | Times Cited: 35
The paradoxical role of MDSCs in inflammatory bowel diseases: From bench to bedside
Fan Zhao, Wenbin Gong, Jiaojiao Song, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Fan Zhao, Wenbin Gong, Jiaojiao Song, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
DNA methylation in the promoters of PD-L1, MMP9, ARG1, galectin-9, TIM-3, VISTA and TGF-β genes in HLA-DR– myeloid cells, compared with HLA-DR+ antigen-presenting cells
Reem Saleh, Salman M. Toor, Rowaida Z. Taha, et al.
Epigenetics (2020) Vol. 15, Iss. 12, pp. 1275-1288
Open Access | Times Cited: 21
Reem Saleh, Salman M. Toor, Rowaida Z. Taha, et al.
Epigenetics (2020) Vol. 15, Iss. 12, pp. 1275-1288
Open Access | Times Cited: 21
Uncovering the Subtype-Specific Molecular Characteristics of Breast Cancer by Multiomics Analysis of Prognosis-Associated Genes, Driver Genes, Signaling Pathways, and Immune Activity
Xia Li, Jian Zhou, Mingming Xiao, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 15
Xia Li, Jian Zhou, Mingming Xiao, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 15
Ginsenosides Regulates Innate Immunity to Affect Immune Microenvironment of AIH Through Hippo-YAP/TAZ Signaling Pathway
Kehui Zhang, Jiacheng Li, Zhe Shi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Kehui Zhang, Jiacheng Li, Zhe Shi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Gr-1 blockade remodels the immunosuppressive microenvironment induced by incomplete microwave ablation of hepatocellular carcinoma
Tian Huang, Hongying Cao, Shipeng Dai, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Tian Huang, Hongying Cao, Shipeng Dai, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
JAK2 gene knockout inhibits corneal allograft rejection in mice by regulating dendritic cell-induced T cell immune tolerance
Jun Hu, Wanping Zhang, Lingjuan Xu, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 3
Jun Hu, Wanping Zhang, Lingjuan Xu, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 3
Interaction of Cell and Gene Therapy with the Immune System
Cheng Yang
Current Gene Therapy (2019) Vol. 19, Iss. 2, pp. 69-70
Closed Access | Times Cited: 1
Cheng Yang
Current Gene Therapy (2019) Vol. 19, Iss. 2, pp. 69-70
Closed Access | Times Cited: 1
